Literature DB >> 22938411

Trends in nasopharyngeal carcinoma mortality in China, 1973-2005.

Tian-Ren Huang1, Si-Wei Zhang, Wan-Qing Chen, Wei Deng, Chun-Yan Zhang, Xin-Juan Zhou, Ri-Hong Zhai.   

Abstract

Nasopharyngeal carcinoma (NPC) is a disease with distinct ethnic and geographic distribution. The incidence of NPC in Chinese residing in Asia has declined over the last few decades, but NPC mortality trends in the entire Chinese population over time have not been systematically evaluated. In this study, we examined NPC mortality at the national level in China between 1973-2005. Mortality rates were derived from the databases of national retrospective surveys on cancer mortality conducted in the periods of 1973-1975, 1990-1992, and 2004-2005, respectively. NPC was classified according to the International classification of diseases. Age-adjusted mortality rates were calculated by direct standardization according to the world standard population. Trends in rates were evaluated by age, gender, geographic areas, and socioeconomic status. From 1973 to 2005, there was a general trend of decrease in NPC mortality in China, with higher rates in the south on a downward trend in the north. The age-standardized NPC mortality rates were 2.60 per 100,000 in 1973-1975, 1.94 per 100,000 in 1990-1992, and 1.30 per 100,000 in 2004-2005, respectively. The trend was similar in both men and women, in both urban and rural areas, but the declining rates in females were more remarkable than in males. The mortality rates were higher for the age groups above 50 years than those less than 50 years of age, both showing downward trend over 30-year period. In summary, the overall NPC mortality has consistently decreased in China over the past three decades, particularly in women and in old adults.

Entities:  

Mesh:

Year:  2012        PMID: 22938411     DOI: 10.7314/apjcp.2012.13.6.2495

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  14 in total

1.  Aberrant expression of CDK5 infers poor outcomes for nasopharyngeal carcinoma patients.

Authors:  Xin Zhang; Tengfei Zhong; Yiwu Dang; Zuyun Li; Ping Li; Gang Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

2.  Upregulation of metastasis-associated gene 2 promotes cell proliferation and invasion in nasopharyngeal carcinoma.

Authors:  Minhua Wu; Xiaoxia Ye; Xubin Deng; Yanxia Wu; Xiaofang Li; Lin Zhang
Journal:  Onco Targets Ther       Date:  2016-03-18       Impact factor: 4.147

3.  Associations of Human Leukocyte Antigen-DRB1 Alleles with Nasopharyngeal Carcinoma and Its Clinical Significance in Xinjiang Uyghur Autonomous Region of China.

Authors:  Xiao-Tao Geng; Yun-Hui Hu; Tao Dong; Ruo-Zheng Wang
Journal:  Chin Med J (Engl)       Date:  2016-06-05       Impact factor: 2.628

4.  Distinctive microRNA expression in early stage nasopharyngeal carcinoma patients.

Authors:  Shuna Li; Lihua Hang; Yongming Ma; Chaoyang Wu
Journal:  J Cell Mol Med       Date:  2016-08-04       Impact factor: 5.310

5.  Prognostic factors for survival of patients with nasopharyngeal carcinoma following conventional fractionation radiotherapy.

Authors:  Fei Kong; Bai-Zhen Cai; Xian-Zhao Chen; Jian Zhang; Yi-Ming Wang
Journal:  Exp Ther Med       Date:  2013-05-08       Impact factor: 2.447

6.  Nasopharyngeal carcinoma incidence and mortality in China in 2009.

Authors:  Zhi-Jian Xu; Rong-Shou Zheng; Si-Wei Zhang; Xiao-Nong Zou; Wan-Qing Chen
Journal:  Chin J Cancer       Date:  2013-07-18

7.  Molecular pathological study of the human nasopharyngeal carcinoma CNE3 cell line.

Authors:  Fei Liu; Wei Jiao; Xiang-Lan Mo; Jiao Lan; Rui-Ping Xiao; Xiang-Zhen Zhou; Zhen-Lu Huang; Xiao-Min Mo; Gang Li
Journal:  Oncol Lett       Date:  2013-08-05       Impact factor: 2.967

8.  Effect of the vascular endothelial growth factor expression level on angiopoietin-2-mediated nasopharyngeal carcinoma growth.

Authors:  Hai-Hong Chen; Bin-Qi Weng; Ke-Jia Cheng; Hong-Yan Liu; Shen-Qing Wang; Yv-Yv Lu
Journal:  Vasc Cell       Date:  2014-03-01

9.  Low expression of Aldo-keto reductase 1B10 is a novel independent prognostic indicator for nasopharyngeal carcinoma.

Authors:  Yuanwei Guo; Weihao Luo; Zheng Hu; Jia Li; Xiaojie Li; Huiqiu Cao; Jun Li; Bo Wen; Jian Zhang; Hao Cheng; Wangyuan Guo; Tan Tan; Dixian Luo
Journal:  Cell Biosci       Date:  2016-03-05       Impact factor: 7.133

10.  Old age at diagnosis increases risk of tumor progression in nasopharyngeal cancer.

Authors:  Jing-Dun Xie; Fu Chen; Yao-Xuan He; Xiao-Di Chen; Guo-Ye Zhang; Zhi-Kun Li; Jing Hong; Dan Xie; Mu-Yan Cai
Journal:  Oncotarget       Date:  2016-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.